<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have explored the factors which influence tumorigenicity of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines in athymic <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="1" pm="."><plain>Four cell lines, Namalwa, CA46, JD38, and ST486 revealed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence of 63.5, 69.0, 45.5 and 10.0%, respectively, in <z:mp ids='MP_0003815'>nude</z:mp> mice, but there was no correlation between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence and growth rate in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, growth rate and tumorigenicity are dependent upon different biochemical pathways </plain></SENT>
<SENT sid="3" pm="."><plain>Evidence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> was demonstrated in the CA46 parent cell line </plain></SENT>
<SENT sid="4" pm="."><plain>Five subclones derived from CA46 revealed varying degrees of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence (but very similar growth rates) that were consistently less than the parent CA46 line </plain></SENT>
<SENT sid="5" pm="."><plain>Line 5, for example, produced 5.7-fold less <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than the parent line </plain></SENT>
<SENT sid="6" pm="."><plain>None of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines or clones produced any metastatic lesions in liver, lung, brain, bone marrow or spleen in athymic <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="7" pm="."><plain>Northern blot analysis of c-myc <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels in different <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines revealed a possible relationship between percent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> takes (but not growth rates) and the level of c-myc oncogene expression </plain></SENT>
<SENT sid="8" pm="."><plain>However, no correlation was observed between c-myc <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence or growth rates among the CA46 clones </plain></SENT>
<SENT sid="9" pm="."><plain>There was no correlation between the ability of the cell lines and the subclones to either secrete growth factors or to respond to growth factors secreted by Epstein-Barr virus-induced lymphoblastoid cells or <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>-activated monocytes, and their growth rates or percent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> takes in mice </plain></SENT>
<SENT sid="10" pm="."><plain>Comparison of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence and growth rates in irradiated and unirradiated mice showed that host factors influenced the growth of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>